Covered recipient · General Payments record
SARAH E PHILLIPS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$574.54
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $445.20 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $210.67 | 6 |
| Lilly USA, LLC | $85.77 | 4 |
| Merck Sharp & Dohme Corporation | $52.43 | 2 |
| Exact Sciences Corporation | $34.17 | 2 |
| CARDIVA MEDICAL, INC. | $27.78 | 1 |
| SANOFI-AVENTIS U.S. LLC | $19.00 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.79 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117655494 | CMS |
| Amgen Inc. | $24.46 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117655496 | CMS |
| Amgen Inc. | $120.84 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117353437 | CMS |
| Amgen Inc. | $15.05 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117655498 | CMS |
| Amgen Inc. | $16.79 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117655500 | CMS |
| Amgen Inc. | $18.74 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117655502 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.38 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086289330 | CMS |
| CARDIVA MEDICAL, INC. | $27.78 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143865223 | CMS |
| Exact Sciences Corporation | $15.31 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114449631 | CMS |
| Exact Sciences Corporation | $18.86 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114449635 | CMS |
| Lilly USA, LLC | $23.88 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135946431 | CMS |
| Lilly USA, LLC | $14.37 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135862531 | CMS |
| Lilly USA, LLC | $23.64 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135940608 | CMS |
| Lilly USA, LLC | $23.88 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135904569 | CMS |
| Merck Sharp & Dohme LLC | $24.71 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141593538 | CMS |
| Merck Sharp & Dohme LLC | $27.72 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141914265 | CMS |
| SANOFI-AVENTIS U.S. LLC | $19.00 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140007720 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.